Dosage and administration
Adults: 1-2 tablets 3 times per day or as directed by a health practitioner. Not to exceed 6 tablets per 24 hours. Children under 18, as directed by a health professional. Allow to completely dissolve in the mouth
Adults: 1-2 tablets 3 times per day or as directed by a health practitioner. Not to exceed 6 tablets per 24 hours. Children under 18, as directed by a health professional. Allow to completely dissolve in the mouth
Keep out of reach of children.
For the temporary relief of minor
urinary pain and urgency.
If pregnant or breast-feeding, ask a
health professional before use. Keep out of reach
of children. If symptoms persist or worsen, a
healthcare provider should be consulted. Do not use
if known sensitivity to BHI Uri-Control or any of its
ingredients exists.
Adults: 1-2 tablets 3 times per day or
as directed by a health practitioner. Not to exceed 6
tablets per 24 hours. Children under 18, as
directed by a health professional. Allow to
completely dissolve in the mouth
Each 300 mg tablet contains:
*Apis mellifica 6X 30mg, Argentum nitricum 6X
30mg, *Belladonna 4X 30mg, *Cantharis 6X 30mg,
Causticum 8X 30mg, *Equisetum hyemale 6X 30mg,
*Petroselinum sativum 8X 30mg, *Pulsatilla 6X
30mg, *Sarsaparilla 6X 30mg, Terebinthina 8X 30mg.
*Natural
*Dextrose, *Lactose,
Magnesium stearate, *Maltodextrin
*contains one or more of these ingredients
Urinary Pain Relief
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6cca4355-1206-91f7-02de-17eef38a8622 | Product name | 1 | 20140508 |
| 751c581a-bf64-2fd7-b3ec-ca02c83e4a00 | Product name | 1 | 20140508 |
| ed912195-5da0-0f2f-6f4b-3ef17710cbe3 | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 62795-9004-2 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-b274-d83d-e063-dadaa90ab31f | BHI Uri-Control |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62795-9004-2 | BHI Uri-Control | 1 in 1 CARTON | TABLET | 1 | 2 | |
| 62795-9004-2 | BHI Uri-Control | 100 in 1 BOTTLE | TABLET | 100 | 2 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 62795-9004 | BHI URI-CONTROL (APIS MELLIFERA, SILVER NITRATE, ATROPA BELLADONNA, LYTTA VESICATORIA, CAUSTICUM, EQUISETUM HYEMALE, PETROSELINUM CRISPUM, PULSATILLA VULGARIS, SMILAX REGELII ROOT, AND TURPENTINE OIL) TABLET [MEDINATURA INC] | 2 | Legacy NDC, 2 package rows | 20230420_4d2184f0-30f3-4d8c-b51e-1a879be25640.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 62795-9004-2 | EA - Each | 62795-9004 | ae0b4f1a-ef7f-49bf-8f43-428bf522c415 | 1 | 2022-05-04 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 62795-9004 | 62795-9004-2 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| APIS MELLIFERA | 7S82P3R43Z | ACTIB |
| SILVER NITRATE | 95IT3W8JZE | ACTIB |
| ATROPA BELLADONNA | WQZ3G9PF0H | ACTIB |
| LYTTA VESICATORIA | 3Q034RO3BT | ACTIB |
| CAUSTICUM | DD5FO1WKFU | ACTIB |
| EQUISETUM HYEMALE | 59677RXH25 | ACTIB |
| PETROSELINUM CRISPUM | 1WZA4Y92EX | ACTIB |
| PULSATILLA VULGARIS | I76KB35JEV | ACTIB |
| SMILAX ORNATA ROOT | 2H1576D5WG | ACTIB |
| TURPENTINE OIL | C5H0QJ6V7F | ACTIB |
| LACTOSE | J2B2A4N98G | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MALTODEXTRIN | 7CVR7L4A2D | IACT |
| DEXTROSE | IY9XDZ35W2 | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a9bfb09f-0839-4421-ad84-dc6ccc211a12 | 4d2184f0-30f3-4d8c-b51e-1a879be25640 | 2023-04-13 | Warnings | a9bfb09f-0839-4421-ad84-dc6ccc211a12 4d2184f0-30f3-4d8c-b51e-1a879be25640 |
Adverse event summaries are temporarily unavailable. Other product information remains available.